Objective To examine hope and its components of agency and pathways as predictors of anxiety and depressive symptoms in children receiving cancer treatment. Methods Sixty patients (mean standard deviation age ¼ 13.3 (2.7); 57% male) completed Snyder's Hope Scales, the Children's Depression Inventory, and the State-Trait Anxiety Inventory at diagnosis and 3 month intervals for 1 year following pediatric cancer diagnosis. Parents also completed Snyder's Hope Scales. Linear mixed-effect regression was used to assess hope's role in longitudinal models of symptoms of depression and anxiety. Results Agency was a significant predictor of between-patient differences and within-patient changes in symptoms of depression and anxiety. Neither patient pathways nor either component of parent hope was predictive of symptoms of depression or anxiety. Patients who were more likely to have depressive symptoms at baseline were older, diagnosed with leukemia, and non-Hispanic White as opposed to Hispanic. Patient demographics were not predictive of anxiety. Conclusion Patient agency is a potential target for intervention to prevent or reduce anxiety and depressive symptoms following pediatric cancer diagnosis.
Hope provides a model for conceptualizing children's adaptive coping and a potential focus for intervention to influence the adjustment of children undergoing cancer treatment. Hope has been described as an "overall perception that one's goals can be met" (Snyder et al., 1997, p. 400 ) and involves two interrelated components: agency and pathways. Pathways involves one's beliefs in one's ability to produce workable routes to desired goals, while agency involves one's beliefs in one's ability to initiate or sustain action toward a desired goal (Snyder, 1994) . Hope, defined in this way, is not specific to a particular goal or situation. The two aspects of hope form the hope thought process, which in turn is theorized to produce positive or negative emotions (Snyder, 2000) .
Hope and its components appear to be theoretically and empirically distinct from other constructs. Hope and optimism share the belief in a positive future, but while optimism's positive outcomes may be from any source or circumstance (Scheier & Carver, 1985) , hope specifically attributes positive expectations to the individuals' capabilities (Snyder, 1994) ; additionally, meta-analysis has found hope to be distinct from optimism (Alarcon, Bowling, & Khazon, 2013) , and both total hope and pathways specifically were separate from optimism in predicting well-being (Magaletta & Oliver, 1999) . Although agency is conceptually similar to self-efficacy (Bandura, 1982) in that both emphasize one's perceived capacity to carry out action, they have also been found to be related but separate predictors of well-being (Magaletta & Oliver, 1999) .
The Role of Hope in Pediatric Cancer
Despite the stress of a cancer diagnosis and the potential for negative thoughts and emotions, the majority of children diagnosed with cancer function well throughout their medical treatments (Patenaude & Kupst, 2005) . Children with cancer appear to be resilient and experience posttraumatic growth (Arpawong, Oland, Milam, Ruccione, & Meeske, 2013; Tillery et al., 2016) , and hope is related to posttraumatic growth in adult survivors of childhood cancer (Yuen, Ho, & Chan, 2014) . Hope may be particularly important for children with health problems, who may need to identify new goals, find different ways to pursue goals, and motivate themselves to continue treatment regimens (Snyder et al., 1997) . Children with cancer often must adhere to complex, time-intensive medical regimens, which could present barriers to their daily functioning, typical development, and social/family relationships (Patenaude & Kupst, 2005) . While barriers to goals are typically associated with negative emotional responses, high-hope people respond to barriers with more positive emotions (Snyder, 2000) . Accordingly, children with cancer and their parents who report high hope may be more capable of identifying solutions to cancer-related challenges, and possess the motivation necessary to persist in the face of stressors (Snyder, 1994) .
While hope may be associated with the emotions prompted by cancer diagnosis, this relationship has not been studied in children undergoing cancer treatment. Cross-sectional research in adult survivors of childhood cancer (Yuen, Ho, & Chan, 2014) , adults with cancer (Rajandram et al., 2011; Shapiro, McCue, Heyman, Dey, & Haller, 2010) , and pediatric populations including healthy adolescents (Lewis & Kleiwer, 1996; Maikranz, Steele, Dreyer, Stratman, & Bovaird, 2007; Yarcheski & Mahon, 2016) has identified an inverse relationship between hope and anxiety and depressive (A/D) symptoms. The influence of parental hope on child A/D symptoms after cancer diagnosis also has not been well-studied. Hope theory posits that hope develops through early interactions between children and their parents and other caregivers (Snyder, 1994) . In support of this theory, parents' attributional style and parenting practices have been related to child hope (Goldner, Scharf, Edelstein, & Havshush, 2015; Kliewer & Lewis, 1995) , while parental hope was positively correlated with children's quality of life (QoL; Santos, Crespo, Canavarro, & Kazak, 2015) . The direct relationship between parent and child hope has not been examined extensively and the results are conflicting (Goldner et al., 2015; Hoy, Suldo, & Mendez, 2013; Santos, Crespo, Canavarro, & Kazak, 2015) . Examining longitudinal relationships between child hope and A/D symptoms, as well as the influence of parent hope on A/D symptoms after pediatric cancer diagnosis, may provide information that would inform conceptualization and targets for intervention.
Initial analyses of this sample (Germann et al., 2015) focused on the longitudinal relationship between symptoms of A/D and Qol, mediated by hope, in children receiving cancer treatment (N¼ 61). Results confirmed the hypothesis that children undergoing cancer treatment are generally well adjusted: Although a subgroup experienced clinically elevated symptoms of anxiety (10%) and depression (26%) at baseline, mean A/D symptoms were below average and decreased further over time. The initial analyses also found that hope was generally high in these patients, improvements in hope predicted improvements in QoL, and improvements in hope partially mediated the effects of A/D symptoms on QoL (Germann et al., 2015) . As hope has not been specifically examined as a longitudinal predictor of symptoms of A/D in a pediatric population undergoing cancer treatment, and building on research which has examined agency and pathways separately (Magaletta & Oliver, 1999) , we sought to understand the differential impact of agency and pathways on symptoms of A/D, to more specifically focus recommendations for intervention. Finally, since the initial analyses did not include parent hope, we sought to understand the influence of parent hope on children's A/D symptoms.
This report describes the longitudinal relationship between hope and symptoms of A/D in children undergoing cancer treatment. We hypothesized that at baseline there would be a cross-sectional (betweenparticipants) negative association between hope and A/D symptoms, and that increasing hope over time (within-participant) would predict decreasing levels of A/D symptoms. We expected that both agency and pathways would be inversely related to A/D symptoms. We hypothesized that parent hope would also be related to participant A/D symptoms.
Method
Participants and Procedure These analyses were part of a study (N ¼ 84) originally designed to examine trajectories of A/D symptoms in children following cancer diagnosis. To enhance the original study, the hope measure was added several months after the start of the study. The analyses presented here focused on a sample of 60 dyads who completed all baseline measures of hope (both parent and child) and A/D symptoms (participants). Eligible participants (N ¼ 124) included patients with a new diagnosis of pediatric cancer and at least one parent/ guardian. Participant eligibility criteria included age 8-17 years, newly diagnosed with cancer (within the past 4 weeks), were expected to receive chemotherapy, life expectancy of greater than 1 year, and primary language of Spanish or English. Exclusion criteria included relapsed malignancy, expected to receive surgery or radiation only, or a previous diagnosis of A/D. Of 124 eligible participants, 87 (70%) consented to participate, 3 participants withdrew from the study, and 24 had incomplete baseline data (17 of whom were enrolled before the addition of the hope measure). Measures were completed at all time points by 39 participants. Compared with participants present at all five visits, those who missed visits did not differ significantly at baseline in any of the demographic and treatment items summarized in Table I : age, sex, race/ethnicity, primary language, type of insurance, or cancer diagnosis (all p > .4). Participants and nonparticipants (those who declined) did not differ by broad diagnostic category (Fisher's exact p ¼ .365), but participants were approximately 1 year older on average (13.2 years vs. 11.9 years; rank-sum p ¼ .028). Participant demographics and treatment variables are presented in Table I .
Eligible participants and their parents were approached for enrollment within 4 weeks of the child's cancer diagnosis, and all parents/participants signed informed consent/assent forms. Participants and their parents completed measures at enrollment and 3-month intervals for the first year following diagnosis. To minimize participant burden and to ensure that any symptom endorsement was not biased by procedures, sick visits, or unscheduled admissions, follow-up study measures were provided on scheduled clinic days without procedures or during scheduled inpatient admissions. Participants were not compensated for their participation. All study procedures were approved by the institutional review board of the host institution.
Measures
Demographic, Life Events, and Treatment Information A socio-demographic data form that included questions about the patient's age, sex, race/ethnicity (categorized as White, Hispanic, and Other for purposes of analysis), and parent primary language was completed. To rule out the potential contribution of other life stressors to patterns of A/D symptoms over the year following cancer diagnosis, life stress was assessed through endorsement of 14 common major life events impacting children and adolescents (Lee et al., 2008) , including events related to illness, peers, family members, school, violence, and the legal system. The total number of endorsed events was used for a total life stress score. Data were also collected from the medical record for the following: family insurance status (private pay vs. public pay), cancer diagnosis, and the intensity of planned cancer treatment. Intensity of planned cancer treatment was coded on a 4-point scale according to the Intensity of Treatment Rating Scale 2.0 (Werba et al., 2007) , which is an objective, reliable (inter-rater reliability r ¼ .87 in the validation study), and validated treatment intensity rating system that classifies cancer and treatments into four levels, least to most intensive.
Depressive Symptoms
The Children's Depression Inventory (CDI) is a 27-item self-report scale designed to assess symptoms of depression in children and adolescents in the past 2 weeks (Kovacs, 1985) . The Total standardized T-score based on population norms (Kovacs, 1985) was used for analyses, and higher scores indicated greater symptoms of depression. Cronbach's alpha was .80, suggesting good internal reliability.
Anxiety Symptoms
The Spielberger State Trait Anxiety Inventory (STAI) and the Spielberger State Trait Anxiety Inventory for Children (age 8-12 years) consist of two 20-item 
self-reporting scales and were designed to distinguish between general anxious disposition (trait) and situational anxiety (state) (Spielberger, 1983) . For the state anxiety scale, participants were instructed to answer the questions according to how they feel "right now." These analyses focused on state anxiety. Standardized t-scores based on population norms (Spielberger, 1983) were used for analyses, and higher scores indicated greater symptoms of anxiety. Cronbach's alpha was .79 for the State scale in the current study, suggesting good internal reliability.
Hope The Children's Hope Scale (Snyder et al., 1997) , titled "Questions About Your Goals" for administration, is a self-report measure that assesses goal-directed thoughts according to pathways (the self-perception of one's ability to find ways to reach goals under ordinary or extraordinary circumstances, e.g., "When I have a problem, I can come up with lots of ways to solve it") and agency (the self-perception of one's ability to initiate and sustain action toward a desired goal, e.g., "I think the things I have done in the past will help me in the future") and is validated for ages 8-16 years. Respondents were asked to "think about how you are in most situations." The scale contains six items on a 6-point Likert scale, and higher scores indicated greater hope (range 6-36). The Hope Scale (Snyder et al., 1991) , titled "The Goals Scale" for administration, is a 12-item self-report measure, which assesses dispositional hope in adults (including agency and pathways), and is validated for ages !15 years. Four items reflect pathways ("I can think of many ways to get out of a jam"), four items reflect agency ("My past experiences have prepared me well for my future"), and four are unscored distractor items. Items are answered on an 8-point Likert scale ("definitely false" to "definitely true," range 8-64). The twofactor structure of both the child and adult scales, convergent and discriminant validity, incremental validity, internal and test-retest reliabilities have been detailed (Snyder et al., 1991; Snyder et al., 1997) . Test-retest reliabilities ranged from .76 to .82 in adult validation samples over 10 weeks (Snyder et al., 1991) and from .71 to .73 in child validation samples (Snyder et al., 1997) . The subscales of agency and pathways were positively but moderately correlated (r ranging from .39 to .61) in validation samples (Snyder et al., 1991; Snyder et al., 1997) . In our study, children <15 years old completed the Children's Hope Scale, and children !15 years old (and parents) completed the Hope Scale. Because the child and adult scales contain different numbers of items, for the patient hope variable, each scale was normalized to a range of 0-100 {Child Hope scale: (total score [6-36] -6)/30 Â 100); Adult Hope scale: (total score [8-64] -8)/56 Â 100}. Similarly, the Agency and Pathways subscales were normalized to a range of 0-50. Normalized hope scores were used for these analyses. In the current study, Cronbach's alphas for the normalized Total Hope, Agency, and Pathways scales, respectively, were 0.90, 0.87, and 0.89 for the participants, and 0.88, 0.90, and 0.83 for the parents, suggesting good internal reliability.
Data Analysis Plan
Simple descriptive statistics were used to characterize participants at their baseline and quarterly visits. Linear mixed-effects regression was used to model the STAI-State anxiety score and the CDI total score of participants over time. All models included fixed longitudinal effects of time and hope. All models also included random intercept and slope (within-patient time) effects to account for correlation among repeated measures of the same individual. By including baseline values of the longitudinal variables as additional covariates, these models simultaneously estimated between-and within-participants submodels (Fitzmaurice, Laird, & Ware, 2011) . To be precise, each longitudinal variable is represented twice in the model at each quarter: first by its baseline value for between-participants information and second by its change from baseline for within-participants information.
Models were fit using Total Hope or, separately, using Agency and Pathways. An adjusted set of models included age, ethnicity, and cancer diagnosis. These variables only-out of a pool of potential additional covariates that also included parent hope, sex, public versus private insurance, intensity of treatment, and life events-were found to be significant in backward selection of the depression model. Effect sizes for Total Hope, Agency, and Pathways were calculated as the corresponding fractional changes in unexplained variation, where the change for each effect was relative to the model with that effect omitted, and the unexplained variation was the sum of residual and random effect variances (intercept for betweenparticipants and slope for within-participants). In a final procedural check of robustness of our models, sensitivity to missing data was assessed by refitting each model excluding participants who missed visits. Models were fit using SAS [SAS/STATV R , version 9.4 (SAS Institute Inc., Cary, NC)] Proc Mixed with restricted/residual likelihood estimation.
Results
Participants' and parents' self-ratings of hope at each time point, as well as longitudinal A/D symptoms, are detailed in Table II . Hope ratings were generally in the upper range for both parents and participants in this study (Table II) ; as comparison, median item response from a mix of healthy and medically ill children was 4.32 (corresponding to a 72 on a normalized scale of 0-100), and 4.31 for children 8-17 years old who had previously received cancer treatment (Snyder et al., 1997) . Whereas participant hope increased over time, parent hope did not change significantly. At baseline, participant agency and pathways were significantly correlated (r ¼ .70, p < .001), as were parent agency and pathways (r ¼ .56, p < .001). Patterns and prevalence of A/D symptoms were similar to those presented in the initial analyses with a similar-sized sample (see Table II and Germann et al., 2015) . In this sample, A/D symptoms were correlated at baseline (r ¼ .54, p < .0001); however, 12 of 17 with clinically significant symptoms of depression at baseline did not have clinically significant symptoms of anxiety.
Hope as a Longitudinal Predictor of A/D Symptoms Hope as Predictor of Depressive Symptoms
Total Hope was examined as a predictor of depressive symptoms in linear mixed-effects regression models (Table III, 1a and 1b) . Total Hope was a significant predictor of between-participant differences and within-participant changes in symptoms of depression (Table III) in the final model including Total Hope and demographic/illness predictors (Table III, 1b) . Between participants at baseline, each þ1 unit difference in Total Hope score was associated with 0.16 lower CDI-Total score. Within participants, each þ1 unit increase in Total Hope score per quarter was associated with 0.12 decrease in CDI-Total per quarter. Translating this into clinical terms based on standard deviations (SD) of hope and depressive symptoms at baseline (Table II) , each SD increase of hope corresponds to a 0.22 SD decrease of depressive symptoms per year. Of the additional predictors evaluated (parent hope, age, sex, race/ethnicity, public vs. private insurance, life events, diagnosis, intensity of treatment), only age, ethnicity, and diagnosis were significant predictors of depressive symptoms. Parent hope did not predict participant depressive symptoms. Participants who were more likely to have depressive symptoms at baseline were older, diagnosed with leukemia, and non-Hispanic White as opposed to Hispanic (Table III) .
The hope components of Agency and Pathways as predictors of depressive symptoms were examined in a separate model (Table III, 2a and 2b) . Agency was a significant predictor of between-participant differences and within-participant changes in symptoms of depression (Table III) in the final model including the hope components and demographic/illness predictors (Table III, 2b) . Between participants at baseline, each þ1 unit difference in Agency score was associated with 0.15 lower CDI-Total score. Within participants over time, each þ1 unit increase in Agency score per quarter was associated with 0.19 decrease in CDITotal per quarter. Pathways did not predict depressive symptoms. As with the Total Hope model, parent hope did not predict participant depressive symptoms and the same demographic/illness predictors were significant predictors of depressive symptoms.
Hope as Predictor of Anxiety Symptoms
Total Hope was examined as a predictor of anxiety symptoms in linear mixed-effects regression models (Table IV, 1a and 1b) . Total Hope was a significant predictor of between-participant differences and within-participant changes in symptoms of anxiety (Table IV) in the final model including Total Hope and demographic/illness predictors (Table IV, 1b) . Between participants at baseline, each þ1 unit difference in Total Hope score was associated with 0.17 lower State Anxiety score. Within participants over time, each þ1 unit increase in Total Hope score per quarter was associated with 0.17 decrease in State Anxiety scores per quarter. Parent hope did not predict participant anxiety, and no significant demographic/illness predictors of anxiety symptoms were found. The hope components of Agency and Pathways as predictors of anxiety symptoms were examined in a separate model (Table IV, 2a and 2b) . Agency was a significant predictor of between-participant differences and within-participant changes in symptoms of anxiety (Table IV) in the final model including the hope components and demographic/illness predictors (Table IV, 2b) . Between participants at baseline, each þ1 unit difference in Agency score was associated with 0.30 lower State Anxiety score. Within participants over time, each þ1 unit increase in Agency score per quarter was associated with 0.28 decrease in State Anxiety score per quarter. Pathways was not a significant predictor of anxiety symptoms. As with the Total Hope model, parent hope was not predictive of participant anxiety symptoms and no demographic/illness predictors were significant predictors of anxiety.
In sensitivity analyses, excluding participants who missed visits had no appreciable effect on the estimated between-and within-participants regression coefficients for Total Hope, Agency or Pathways, and no effect on their significance.
Discussion
This study, which examined the longitudinal relationship between hope and A/D symptoms in children undergoing cancer treatment, partially supported our hypotheses that hope, and both of its components of agency and pathways, would be negatively associated with A/D symptoms. We identified that improvements in A/D symptoms after pediatric cancer diagnosis were significantly related to changes in hope generally, and to the agency component of hope specifically (but not to pathways). The longitudinal nature of this study and its focus on children actively undergoing cancer treatment advances the literature which was previously limited to cross-sectional studies of hope's relationship to A/D in adults with cancer, adult survivors of childhood cancer, and non-cancer pediatric and healthy child populations, and which did not include the ethnic diversity (33% Hispanic) of our sample (Maikranz et al., 2007; Rajandram et al., 2011; Shapiro et al., 2010; Yuen et al., 2014) . Our findings did not support our hypothesis that parent hope would be related to participant A/D symptoms; however, the inclusion of parental hope in this study, and its lack of impact on child A/D symptoms, adds to a literature which has been limited to cross-sectional inconsistencies of the relationship of parent hope to child hope (Goldner et al., 2015; Hoy, Suldo, & Mendez, 2013; Santos et al., 2015) . Direction of causation cannot be determined from this study; however, our results suggest that the cognitive processes involved with hope and goal pursuit may impact A/D symptoms in the context of childhood cancer diagnosis and treatment. Our findings are consistent with research that found low hindrance of goal pursuits to be related to well-being (Schwartz & Drotar, 2009 ) but further emphasizes the potential for a cognitive intervention; specifically, hope reflects the individual's changeable belief in their ability to pursue multiple routes to their goals.
The particular predictive nature of agency has important implications for clinical intervention development. Our findings are consistent with Magaletta & Oliver (1999) who found agency to be a better predictor of well-being than pathways. While pediatric cancer patients may have a variety of goals (adherence, managing side effects, connects to family and friends, survival), and may generate a variety of alternative strategies (pathways), some may lack the motivation or energy (agency) to pursue or achieve their goals, owing to dispositional (e.g., low motivation), illness (e.g., fatigue, nausea, pain), or situational factors (e.g., family stress, school absence, and restricted opportunities for socialization). Researched interventions have not yet been agency-focused. Suggestions for future development and evaluation of hopefocused, and more specifically, agency-focused, interventions, are two-fold:
1. There is a need to examine the effects on A/D symptoms of interventions which increase hope. First, it is not known if hope is a mediator of change in established interventions. Evidence-based interventions, such as motivational interviewing or cognitive-behavioral therapy, have not been widely studied in children receiving cancer treatment, but may have the ability to increase the motivation and energy (agency) for goal pursuit. Second, there is promising data regarding interventions that increase hope in adults (Lopez et al., 2000) ; however, this has not been studied in children. Because agency has the potential to impact symptoms of both A/D, the development and evaluation of an agency-specific intervention may be particularly clinically efficient and useful. An agencyspecific intervention, which would focus on enhancing a person's perceived capabilities to begin and maintain movement toward a desired goal, might include identifying barriers to initiating action, identifying past successful strategies for completing challenging tasks in the past, using positive visualization to envision past and future processes of pursuing a goal (Lopez et al., 2000) , and addressing inhibitors of mental and physical energy (e.g., side effects, sleep hygiene, poor nutrition). 2. Qualitative analysis of the experiences of child, adolescent, and young adult cancer patients who have high hope and low A/D symptoms could yield further insights into not only the strategies they use (pathways), but also how they initiate and sustain action (agency) toward their goals despite interference from cancer and treatment regimens. A semi-structured interview geared toward the processes of goal attainment would be beneficial in identifying the mechanisms through which patients use hope to manage emotions. Once these mechanisms are more understood, intervention researchers would have a better understanding of whether established interventions can simply be enhanced to promote hope specifically (e.g., modifying or enhancing cognitive-behavioral interventions to promote agency), or whether a stand-alone hope intervention would be most efficacious. Qualitative analyses may also help elucidate if and how parent hope influences the goal pursuit of pediatric cancer patients.
Limitations of this study inform future research. The generalizability of results to the pediatric cancer population is somewhat limited, as our sample excluded patients with brain tumors receiving radiation or surgery only, and excluded patients aged <8 years. Those who participated may have had less distress than those who declined, resulting in potential overestimation of the adjustment of this population; however, they nevertheless demonstrated significant improvements in A/D symptoms and hope without intervention. The significant agency finding also may not be generalizable to other populations. The children in this sample were all experiencing a similar life event (cancer); the impact of agency may be different in children experiencing different types of life stress. Although we identified risk factors for depressive symptoms in children diagnosed with cancer, we did not directly examine whether hope differed according to demographics or prognostic factors; it is possible that despite the overall high survival rates in pediatric cancer, some diagnostic groups which have lower rates of survival may show different patterns of hope during treatment. Because of the descriptive nature of the original design, this study compared patient A/D symptoms to published standardized norms rather than using a comparison group; future hope studies would benefit from comparison with healthy populations or other chronic health populations, as they may experience a different pattern of hope with their unique disease process. While the child and adult hope measures were both developed from the same theory, it is possible they are assessing slightly different constructs; therefore, to facilitate measurement equivalence, future pediatric research should use The Children's Hope Scale (Snyder et al., 1997) across patient participants, regardless of age (i.e., beyond the validated age of 15 years), as has been implemented in previous literature (Maikranz et al., 2007) .
This study adds to the literature through its prospective, longitudinal design and the frequency of screening administrations, which allowed for an examination of hope as a changeable state that may impact A/D symptoms over time. Children with pediatric cancers are resilient, and both high hope at diagnosis and increasing hope during treatment, predict lower A/D symptoms. Further understanding of the hope process in children, adolescents, and young adults with cancer is needed to inform the development and/or modifications of hope interventions.
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